Stay updated with breaking news from Phase 3. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Independent biopharmaceutical company Specialised Therapeutics Asia Pte Ltd (ST) has signed a license deal with Korea-based CanariaBio Inc., acquiring the exclusive license to a new monoclonal antibody therapy for patients with ovarian cancer in Australia, New Zealand and in select Southeast Asian countries.
The findings from these 2 trials for bimekizumab may lead to greater treatment options for patients with HS, an often debilitating and chronic skin condition.
Discover Dubuque's Q Casino's multi-year makeover as it embarks on Phases 2 and 3, part of a $75-80 million revitalization plan to reshape Schmitt Island.
Discover Dubuque's Q Casino's multi-year makeover as it embarks on Phases 2 and 3, part of a $75-80 million revitalization plan to reshape Schmitt Island.
Interim results from the phase 3 APPLAUSE-IgAN study showed a statistically significant reduction in proteinuria among patients treated with iptacopan compared to placebo.